Regulation of pharmaceutical innovation : The 1962 amendments

The production of these effects would not necessarily tell us anything about the costs and benefits of the 1962 amendments. The costs and benefits would depend on the value of the particular drugs kept off the market by the amendments and the value of the information on new drugs generated by more e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Peltzman, Sam
Formato: Libro
Lenguaje:Undetermined
Publicado: Washington American Enterprise Institute for Public Policy Research 1974
Materias:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Thư viện lưu trữ: Trung tâm Học liệu Trường Đại học Cần Thơ

Ejemplares similares